Related Experiment Video
Updated: May 27, 2026

Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
Published on: June 23, 2019
Atherosclerosis: pathogenesis and increased occurrence in individuals with HIV and Mycobacterium tuberculosis
Timothy Guilford1, Devin Morris, Dennis Gray
1Your Energy Systems, Palo Alto, CA, USA.
Insights
Oxidized LDL impairs macrophage function, increasing susceptibility to Mycobacterium tuberculosis infection in individuals with atherosclerosis, especially those with HIV. This highlights a critical link between cardiovascular disease and infectious disease risk.
Area of Science:
- Immunology
- Cardiovascular Disease
- Infectious Disease
Background:
- Atherosclerosis, a major cause of heart disease and stroke, is linked to increased risk in HIV-infected individuals.
- Human Immunodeficiency Virus (HIV) damages CD4+ T cells, impairing immune function and increasing susceptibility to opportunistic infections like tuberculosis.
- Acquired Immunodeficiency Syndrome (AIDS) is a significant public health concern in the US, with over 1 million Americans potentially infected with HIV.
Purpose of the Study:
- To review the impact of oxidized low-density lipoproteins (oxLDL) on macrophage function.
- To examine how oxLDL-impaired macrophages influence susceptibility to Mycobacterium tuberculosis infection.
- To compare these effects in individuals with atherosclerosis, with and without HIV infection.
Main Methods:
- Literature review summarizing existing research on oxLDL, macrophage function, and Mycobacterium tuberculosis.
- Analysis of studies investigating the interplay between HIV, atherosclerosis, and immune response.
- Synthesis of findings related to cellular mechanisms and disease susceptibility.
Main Results:
- Oxidized low-density lipoproteins impair macrophage functions critical for combating infections.
- This impairment is exacerbated in individuals with atherosclerosis, particularly those co-infected with HIV.
- Compromised macrophage function enhances susceptibility to Mycobacterium tuberculosis infection.
Conclusions:
- Oxidized LDL plays a key role in macrophage dysfunction within the context of atherosclerosis and HIV.
- This dysfunction increases the risk and severity of Mycobacterium tuberculosis infections in vulnerable populations.
- Understanding these mechanisms is crucial for developing targeted therapeutic strategies.
Abstract:
Atherosclerosis is a leading cause of coronary heart disease and stroke. Since 1981, more than 980,000 cases of AIDS have been reported in the United States. According to the Centers for Disease Control, more than 1 million Americans may be infected with HIV. By killing or damaging CD4+ T cells of the body's immune system, HIV progressively destroys the body's ability to fight infections. People diagnosed with AIDS often suffer from life-threatening diseases caused by opportunistic infections such as tuberculosis. HIV-infected individuals have increased risks for atherosclerosis. This review summarizes the effects of oxidized low density lipoproteins in impairing macrophage functions in individuals with atherosclerosis (with and without HIV infection) thereby enhancing the susceptibility to Mycobacterium tuberculosis infection.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Atherosclerosis I: Introduction
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Coronary Artery Disease II: Pathophysiology
Peripheral Artery Disease I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

